Device Newcomer And Pharma Giant Expand Partnership
This article was originally published in The Gray Sheet
Executive Summary
Merck is buying an 11% stake in device maker FoxHollow, expanding a previous agreement to use plaque isolated from patients' arteries for pharmaceutical research